Cargando…

Return to Work after Breast Reduction: A Comparative Study

(1) Background: Breast hypertrophy is a prevalent condition among women worldwide, which can affect different aspects of their quality of life. Uncertainty exists in the medical literature about recommendations for return to work after reduction mammaplasty procedures. The aim of this study was to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Holopainen, Nora, Oranges, Carlo M., di Summa, Pietro G., Toia, Francesca, Giordano, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863652/
https://www.ncbi.nlm.nih.gov/pubmed/36675571
http://dx.doi.org/10.3390/jcm12020642
_version_ 1784875387683078144
author Holopainen, Nora
Oranges, Carlo M.
di Summa, Pietro G.
Toia, Francesca
Giordano, Salvatore
author_facet Holopainen, Nora
Oranges, Carlo M.
di Summa, Pietro G.
Toia, Francesca
Giordano, Salvatore
author_sort Holopainen, Nora
collection PubMed
description (1) Background: Breast hypertrophy is a prevalent condition among women worldwide, which can affect different aspects of their quality of life. Uncertainty exists in the medical literature about recommendations for return to work after reduction mammaplasty procedures. The aim of this study was to assess the return to work after reduction mammaplasty for women with breast hypertrophy. (2) Methods: A retrospective cohort study composed of chart review of all reduction mammaplasties performed at a single institution due to breast hypertrophy was considered. Patients not in working life were excluded. Patients were divided into two groups based on the sick leave duration: normal versus prolonged. Prolonged sick leave time was defined as times greater than the 75th percentile for the respective sample data. Demographic and comorbidity data were secondary predictor variables. The primary outcome measure was the occurrence of prolonged sick leave. Secondary endpoints were specific wound healing complications and late complications. We further compare postoperative complications between patients who received a sick leave of 3 weeks versus the other patient cohort. (3) Results: From a total of 490 patients, 407 of them were employed at intake. Mean time to working return after reduction mammaplasty was 4.0 ± 0.9 weeks. Prolonged sick leave occurred in 77 patients and its mean duration was 5.5 ± 0.9 weeks. No differences in age, preoperative BMI, smoking, comorbidities, number of children or use of herbal supplements were detected. Significantly increased intraoperative blood loss occurred in the group who received prolonged sick leave (328.3 mL vs. 279.2 mL, p = 0.031). Postoperative complications were significantly higher in the group who experienced a prolonged sick leave (26.5% vs. 11.2%, p < 0.001), particularly infections and wound dehiscence incidences. No differences in late complications were detected (>30 days, 6.5% vs. 7.6%, p = 0.729). When comparing patients who received a 3 week sick leave with the rest of cohort, blood loss was significantly higher in the group who had a longer sick leave (230.9 mL vs. 303.7 mL, p < 0.001). (4) Conclusions: The occurrence of postoperative complications increased the patients’ return to work time. Comorbidities and preoperative parameters did not affect the length of sick leave. It appears reasonable to suggest a recovery period of approximately 3 weeks, subject to individual variations. An increased intraoperative blood loss might predict a prolonged sick leave.
format Online
Article
Text
id pubmed-9863652
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98636522023-01-22 Return to Work after Breast Reduction: A Comparative Study Holopainen, Nora Oranges, Carlo M. di Summa, Pietro G. Toia, Francesca Giordano, Salvatore J Clin Med Article (1) Background: Breast hypertrophy is a prevalent condition among women worldwide, which can affect different aspects of their quality of life. Uncertainty exists in the medical literature about recommendations for return to work after reduction mammaplasty procedures. The aim of this study was to assess the return to work after reduction mammaplasty for women with breast hypertrophy. (2) Methods: A retrospective cohort study composed of chart review of all reduction mammaplasties performed at a single institution due to breast hypertrophy was considered. Patients not in working life were excluded. Patients were divided into two groups based on the sick leave duration: normal versus prolonged. Prolonged sick leave time was defined as times greater than the 75th percentile for the respective sample data. Demographic and comorbidity data were secondary predictor variables. The primary outcome measure was the occurrence of prolonged sick leave. Secondary endpoints were specific wound healing complications and late complications. We further compare postoperative complications between patients who received a sick leave of 3 weeks versus the other patient cohort. (3) Results: From a total of 490 patients, 407 of them were employed at intake. Mean time to working return after reduction mammaplasty was 4.0 ± 0.9 weeks. Prolonged sick leave occurred in 77 patients and its mean duration was 5.5 ± 0.9 weeks. No differences in age, preoperative BMI, smoking, comorbidities, number of children or use of herbal supplements were detected. Significantly increased intraoperative blood loss occurred in the group who received prolonged sick leave (328.3 mL vs. 279.2 mL, p = 0.031). Postoperative complications were significantly higher in the group who experienced a prolonged sick leave (26.5% vs. 11.2%, p < 0.001), particularly infections and wound dehiscence incidences. No differences in late complications were detected (>30 days, 6.5% vs. 7.6%, p = 0.729). When comparing patients who received a 3 week sick leave with the rest of cohort, blood loss was significantly higher in the group who had a longer sick leave (230.9 mL vs. 303.7 mL, p < 0.001). (4) Conclusions: The occurrence of postoperative complications increased the patients’ return to work time. Comorbidities and preoperative parameters did not affect the length of sick leave. It appears reasonable to suggest a recovery period of approximately 3 weeks, subject to individual variations. An increased intraoperative blood loss might predict a prolonged sick leave. MDPI 2023-01-13 /pmc/articles/PMC9863652/ /pubmed/36675571 http://dx.doi.org/10.3390/jcm12020642 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Holopainen, Nora
Oranges, Carlo M.
di Summa, Pietro G.
Toia, Francesca
Giordano, Salvatore
Return to Work after Breast Reduction: A Comparative Study
title Return to Work after Breast Reduction: A Comparative Study
title_full Return to Work after Breast Reduction: A Comparative Study
title_fullStr Return to Work after Breast Reduction: A Comparative Study
title_full_unstemmed Return to Work after Breast Reduction: A Comparative Study
title_short Return to Work after Breast Reduction: A Comparative Study
title_sort return to work after breast reduction: a comparative study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863652/
https://www.ncbi.nlm.nih.gov/pubmed/36675571
http://dx.doi.org/10.3390/jcm12020642
work_keys_str_mv AT holopainennora returntoworkafterbreastreductionacomparativestudy
AT orangescarlom returntoworkafterbreastreductionacomparativestudy
AT disummapietrog returntoworkafterbreastreductionacomparativestudy
AT toiafrancesca returntoworkafterbreastreductionacomparativestudy
AT giordanosalvatore returntoworkafterbreastreductionacomparativestudy